Insulet (PODD) Gross Margin (2010 - 2026)
Insulet (PODD) posted Gross Margin of 69.46% for Q1 2026, down 4.25% on a QoQ basis from 72.54% in Q4 2025, and down 242.0% year-over-year from 48.92% in Q1 2025.
Insulet (PODD) Gross Margin (2010 - 2026) Analysis & Trends
Insulet's Gross Margin history runs 17 years deep, the most recent figure standing at 69.46% for Q1 2026.
- Quarterly Gross Margin fell 242.0% year-over-year to 69.46% in Q1 2026, while the trailing twelve-month figure through Mar 2026 was 71.01% (up 62.0% YoY) and the FY2025 annual result came in at 71.63%, up 185.0% from the prior year.
- Gross Margin was 69.46% for Q1 2026 at Insulet, down from 72.54% in the prior quarter.
- Across five years, Gross Margin topped out at 72.54% in Q4 2025 and bottomed at 55.25% in Q3 2022.
- A 5-year average of 67.98% and a median of 69.46% in 2024 frame the typical range for Gross Margin.
- Annual changes were most pronounced in 2022 — Gross Margin tumbled 1683 bps — and 2023, when it jumped 1253 bps.
- Insulet's Gross Margin stood at 58.78% in 2022, then rose by 21 bps to 70.85% in 2023, then increased by 2 bps to 72.12% in 2024, then gained by 1 bps to 72.54% in 2025, then declined by 4 bps to 69.46% in 2026.
- Business Quant data shows PODD's Gross Margin at 69.46% in Q1 2026, 72.54% in Q4 2025, and 72.22% in Q3 2025.
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Gross Margin (Qtr) |
|---|---|---|---|---|---|
| 1 | Abbott Laboratories | 182.52 Bn | 175.22 Bn | 6.27 Bn | 56.20% |
| 2 | Stryker | 128.96 Bn | 126.09 Bn | 3.81 Bn | 63.29% |
| 3 | Medtronic | 107.99 Bn | 98.77 Bn | 6.41 Bn | 65.35% |
| 4 | Boston Scientific | 67.76 Bn | 66.31 Bn | 3.61 Bn | 69.46% |
| 5 | Edwards Lifesciences | 48.09 Bn | 44.41 Bn | 1.29 Bn | 78.01% |
| 6 | Dexcom | 28.30 Bn | 27.18 Bn | 750.30 Mn | 62.95% |
| 7 | GE HealthCare Technologies | 27.89 Bn | 25.61 Bn | 1.98 Bn | 38.53% |
| 8 | Smith & Nephew | 27.02 Bn | 26.45 Bn | - | - |
| 9 | Koninklijke Philips | 23.98 Bn | 20.86 Bn | 2.07 Bn | 45.22% |
| 10 | Insulet | 11.56 Bn | 11.07 Bn | 529.10 Mn | 69.46% |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | 69.46% |
| Dec 31, 2025 | 72.54% |
| Sep 30, 2025 | 72.22% |
| Jun 30, 2025 | 69.67% |
| Mar 31, 2025 | 71.88% |
| Dec 31, 2024 | 72.12% |
| Sep 30, 2024 | 69.33% |
| Jun 30, 2024 | 67.74% |
| Mar 31, 2024 | 69.46% |
| Dec 31, 2023 | 70.85% |
| Sep 30, 2023 | 67.78% |
| Jun 30, 2023 | 66.81% |
| Mar 31, 2023 | 67.16% |
| Dec 31, 2022 | 58.78% |
| Sep 30, 2022 | 55.25% |
| Jun 30, 2022 | 63.56% |
| Mar 31, 2022 | 70.99% |
| Dec 31, 2021 | 69.29% |
| Sep 30, 2021 | 72.08% |
| Jun 30, 2021 | 70.30% |